Atlas Trials

The Effect of Methylprednisolone on the Reversal Time of Rocuronium by Sugammadex in the Pediatric Patient Group

Clinical trial NCT06623370 · COMPLETED

Trial details

NCT number
NCT06623370
Sponsor
Konya City Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Sugammadex Reversal TimeMuscle Weakness
Start date
2024-10-01
Primary completion
2025-01-17
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.